Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Cessation of Somatostatin Analogues for Neuroendocrine Tumors
Recruiting1 awardPhase 2
Ottawa, Ontario
This trial aims to understand the outcomes of patients with slow-growing neuroendocrine tumors who have not responded well to standard treatment with somatostatin analogues. These tumors can be functional (overprodu
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service